Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives
Subject
Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine